In recent years, SETD2 has attracted interest as a potential tumor suppressor gene, whose inactivation would therefor participate to tumor initiation and progression for a wide range of human tumors, including epithelial, central nervous system, and hematopoietic tumors6,50–53. The gene discussed is SETD2; the disease is neoplasm.